Why the study?
Hypertension management in elderly patients often involves multiple co-morbidities leading to increased polypharmacy, highlighting the need to identify its impact on health-related quality of life.
Does polypharmacy reduce health-related quality of life in patients with hypertension?
Population
100 hypertensive patients at a rural tertiary care hospital in Wardha District
Comparison
Polypharmacy vs non-polypharmacy based on number of medications
Design
Cross-sectional observational study
Authors
Loading...
Polypharmacy was associated with lower HRQoL in hypertension; hypothesis-generating and requires prospective confirmation before practice change.
Does polypharmacy reduce health-related quality of life in patients with hypertension?
Polypharmacy is associated with a significantly lower physical and mental health-related quality of life in patients with hypertension.
Paramba et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: